Drawing for VITALANT

USPTO serial 87907309

VITALANT

Reviewed by CopyMark Law Group

Reg. 5846478Status 710
Filing date
Status date
Registration date
Aug 27, 2019
Examiner
EISNACH, MICHAEL PATRICK
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with VITALANT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Emily A. Bayton

Emily A. Bayton FAEGRE DRINKER BIDDLE & REATH LLP1144 15th Street, Suite 3400Denver, CO 80202UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Inventory management in the field of biologic and specialty pharmaceutical products in the nature of therapeutic plasma-derivatives and recombinant coagulation products provided to hospitals, clinics, home care companies, hemophilia and thrombosis centers, and physician offices; promoting public awareness of the need for blood donors, namely, public awareness about blood products and community blood bank centers; arranging procurement of goods for others in the field of human bone, tissue, and organs for purposes of transplantation; and distributorship services in the field of human blood and blood products, therapeutic plasma-derivatives and recombinant coagulation productsSECTION 8 - CANCELLEDSep 24, 2018
036Charitable fundraising services in the field of human blood and blood products to support blood bank operations and research in the field of transfusion medicineSECTION 8 - CANCELLEDSep 24, 2018
039Storage of human bone, tissue, and organs for purposes of transplantationSECTION 8 - CANCELLEDSep 24, 2018
040Processing of human bone, tissue, and organs for purposes of transplantationSECTION 8 - CANCELLEDSep 24, 2018
041Providing training and continuing professional education courses in the field of health, safety, medicine, immunology, blood banking, transfusion and human resources and business management in the transfusion medicine and blood banking laboratory fields; educational services, namely, providing educational materials to the general public and health care professionals about blood donation and transfusion in connection with providing the aforementioned educational servicesSECTION 8 - CANCELLEDSep 24, 2018
042Laboratory, clinical and translational research in the field of transfusion medicine, and infectious disease; blood analysis services; medical blood laboratory services; medical research in the field of blood; and providing quality assurance services in the field of blood and blood productsSECTION 8 - CANCELLEDSep 24, 2018
044Blood bank services, namely, collection, supply, preservation, distribution, and coordination of human blood and blood products; organ and tissue bank services; medical testing of blood; blood bank services, namely, processing of bloodSECTION 8 - CANCELLEDSep 24, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 13, 2026C8..CANCELLED SEC. 8 (6-YR)—
Aug 27, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jul 26, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 26, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 26, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 26, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 26, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Nov 13, 2019ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Aug 27, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 26, 2019SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jul 25, 2019CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jul 25, 2019DOCKASSIGNED TO EXAMINER—
May 25, 2019SUPCSTATEMENT OF USE PROCESSING COMPLETE—
May 25, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 13, 2019IUAFUSE AMENDMENT FILED—
May 13, 2019EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Dec 18, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 23, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 23, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 3, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 15, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 15, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Sep 15, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 15, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 15, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 13, 2018ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Sep 4, 2018PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Aug 21, 2018ALIEASSIGNED TO LIE—
Aug 2, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 1, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 19, 2018GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Jul 19, 2018GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Jul 19, 2018EPENCOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY—
Jul 19, 2018CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Jul 12, 2018DOCKASSIGNED TO EXAMINER—
May 15, 2018MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
May 14, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 8, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance